HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The creation of the artificial RING finger from the cross-brace zinc finger by alpha-helical region substitution.

Abstract
The creation of the artificial RING finger as ubiquitin-ligating enzyme (E3) has been demonstrated. In this study, by the alpha-helical region substitution between the EL5 RING finger and the Williams-Beuren syndrome transcription factor (WSTF) PHD finger, the artificial E3 (WSTF PHD_RING finger) was newly created. The experiments of the chemical modification of residues Cys and the circular dichroism spectra revealed that the WSTF PHD_RING finger binds two zinc atoms and adopts the zinc-dependent ordered-structure. In the substrate-independent ubiquitination assay, the WSTF PHD_RING finger functions as E3 and was poly- or mono-ubiquitinated. The present strategy is very simple and convenient, and consequently it might be widely applicable to the creation of various artificial E3 RING fingers with the specific ubiquitin-conjugating enzyme (E2)-binding capability.
AuthorsKazuhide Miyamoto, Kayo Togiya
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 394 Issue 4 Pg. 972-5 (Apr 16 2010) ISSN: 1090-2104 [Electronic] United States
PMID20307496 (Publication Type: Journal Article)
Copyright2010 Elsevier Inc. All rights reserved.
Chemical References
  • BAZ1B protein, human
  • Transcription Factors
  • Ubiquitin-Protein Ligases
  • Zinc
  • Cysteine
Topics
  • Amino Acid Sequence
  • Cysteine (chemistry)
  • Humans
  • Molecular Sequence Data
  • Protein Folding
  • Protein Structure, Secondary
  • RING Finger Domains
  • Transcription Factors (chemistry)
  • Ubiquitin-Protein Ligases (chemical synthesis, chemistry)
  • Ubiquitination
  • Zinc (chemistry)
  • Zinc Fingers

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: